Author

Stephan Miehlke 1

1 Coopertion of Internal Medicine Center for Digestive Diseases,Hamburg,Germany

A novel budesonide orodispersible tablet formulation is highly effective to maintain endoscopic inflammatory remission and even complete endoscopic remission in adult patients with eosinophilic esophagitis: Results from the 48-weeks, double-blind, placebo-controlled pivotal EOS-2 trial

Luc Biedermann, Alfredo J. Lucendo, Stephan Miehlke, Christoph Schlag, Cecilio Santander Vaquero, Constanza Ciriza De Los Ríos, Dirk Hartmann, Ahmed Madisch, Petr Hruz, Jamal Hayat, Ulrike von Arnim, Arjan Bredenoord, Ralph Müller, Roland Greinwald, Alain Schoepfer, Stephen E. Attwood, Alex Straumann

A NOVEL BUDESONIDE ORODISPERSIBLE TABLET WITH A SPECIAL ESOPHAGEAL-TARGETING CAN INDUCE COMPLETE CLINICAL, ENDOSCOPIC AND HISTOLOGIC REMISSION IN ACTIVE EOSINOPHILIC ESOPHAGITIS: RESULTS FROM A POST-HOC ANALYSIS OF THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED EOS-1 TRIAL

Stephan Miehlke

A novel budesonide orodispersible tablet with a special esophageal-targeting can induce complete clinical, endoscopic and histologic remission in active Eosinophilic Esophagitis: Results from a post-hoc analysis of the randomized, double-blind, placebo-controlled EOS-1 trial

Stephan Miehlke, Christoph Schlag, Alex Straumann, Michael Vieth, Ralph Mueller, Roland Greinwald, Alfredo J. Lucendo

A novel oral budesonide formulation is highly effective for induction of remission in patients with active eosinophilic esophagitis: Results from the 6-weeks open-label treatment phase of EOS-2 trial

Alfredo J. Lucendo, Christoph Schlag, Stephan Miehlke, Luc Biedermann, Cecilio Santander Vaquero, Dirk Hartmann, Jamal Hayat, Petr Hruz, Constanza Ciriza De Los Ríos, Arjan Bredenoord, Michael Vieth, Ralph Müller, Roland Greinwald, Alex Straumann

A RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PLACEBO-CONTROLLED, EUROPEAN MULTICENTRE TRIAL OF TWO NEW BUDESONIDE FORMULATIONS FOR TREATMENT OF ACTIVE EOSINOPHILIC ESOPHAGITIS

Petr Hruz, Stephan Miehlke, Ulrike von Arnim, Ahmed Madisch, Michael Vieth, Christiane Fibbe, Henning Wittenburg, Hans-Dieter Allescher, Max Reinshagen, Stefan Schubert, Jan Tack, Michaela Müller, Alexander J. Eckardt, Patrick Krummenerl, Joris Arts, Karin Dilger, Roland Greinwald, Alex Straumann

BUDESONIDE IS SUPERIOR TO MESALAZINE AND PLACEBO FOR INDUCTION OF REMISSION IN LYMPHOCYTIC COLITIS

Stephan Miehlke, Daniela Aust, Emese Mihaly, Peter Armerding, Guenther Boehm, Ole Kristian Bonderup, Fernando Fernández-Bañares, Juozas Kupcinskas, Lars Kristian Munck, Kai-Uwe Rehbehn, Tanju Nacak, Roland Greinwald, Andreas Münch

Budesonide orodispersible tablets are superior to maintain and even further improve quality of life in adult patients with eosinophilic esophagitis: Results from the 48-weeks, double-blind, placebo-controlled pivotal EOS-2 trial

Christoph Schlag, Luc Biedermann, Alfredo J. Lucendo, Stephan Miehlke, Cecilio Santander Vaquero, Constanza Ciriza De Los Ríos, Dirk Hartmann, Ahmed Madisch, Petr Hruz, Jamal Hayat, Ulrike von Arnim, Arjan Bredenoord, Ralph Müller, Roland Greinwald, Alain Schoepfer, Stephen E. Attwood, Alex Straumann

Budesonide orodispersible tablets are superior to maintain combined clinical and histological remission in adult patients with eosinophilic esophagitis: Results from the 48-weeks, double-blind, placebo-controlled pivotal EOS-2 trial

Alex Straumann, Alfredo J. Lucendo, Stephan Miehlke, Michael Vieth, Christoph Schlag, Luc Biedermann, Cecilio Santander Vaquero, Constanza Ciriza De Los Ríos, Dirk Hartmann, Ahmed Madisch, Petr Hruz, Jamal Hayat, Ulrike von Arnim, Arjan Bredenoord, Stefan Schubert, Ralph Müller, Roland Greinwald, Alain Schoepfer, Stephen

DEMOGRAPHICS AND PROGNOSIS OF INCIDENT PATIENTS WITH MICROSCOPIC COLITIS–FIRST RESULTS OF THE EUROPEAN PRO-MC COLLABORATION, A LINK-AWARD PROJECT

Bas Verhaegh, Andreas Münch, Wojciech Cebula, Signe Wildt, Andreea-Raluca Dia Diac, Svetlana Meisner, Natalia Pedersen, Fernando Fernández-Bañares, Danila Guanozzi, Alfredo J. Lucendo, Johan Bohr, Gilles Macaigne, Gian E. Tontini, Juozas Kupcinskas, Magid AR Al-Khalaf, Plamen Penchev, Stephan Miehlke, Henrik Hjortswang, M

DISEASE COURSE AND PROGNOSIS OF INCIDENT PATIENTS WITH MICROSCOPIC COLITIS - ONE YEAR FOLLOW-UP RESULTS. THE EUROPEAN PRO-MC COLLABORATION, A LINK AWARD PROJECT

Bas PM Verhaegh, Signe Wildt, Andreas Münch, Wojciech Cebula, Andreea-Raluca Diac, Svetlana Meisner, Natalia Pedersen, Fernando Fernández-Bañares, Danila Guagnozzi, Alfredo J. Lucendo, Johan Bohr, Gilles Macaigne, Gian Eugenio Tontini, Jonas Kupcinskas, Magid Al-khalaf, Plamen Penchev, Stephan Miehlke, Henrik Hjortswang,

Item 1 - 10 / 34
1
2 3 4